300
Participants
Start Date
May 29, 2023
Primary Completion Date
January 31, 2024
Study Completion Date
January 31, 2027
BCD-263
BCD-263 at a dose 480 mg administered intravenously every 4 weeks up to 6 cycles
Opdivo
Opdivo at a dose 480 mg administered intravenously every 4 weeks up to 6 cycles
"Russian Cancer Research Center named after N.N. Blokhin of the Ministry of Health of the Russian Federation", Moscow
"Regional State Budgetary of Healthcare Insti-tution Kostroma Clinical Oncology Dispensary", Kostroma
"State Budgetary Institution of Healthcare of the Arkhangelsk Region Severodvinsk City Hospital №2 of Emergency", Arkhangelsk
"JSC Modern Medical Technologies", Saint Petersburg
"Private healthcare institution Clinical hospital RZD-Medicine of the city of Saint Petersburg", Saint Petersburg
"Healthcare Institution Minsk City Clinical Cancer Center", Minsk
"State Institution Republic Scientific and Practical Centre for Oncology and Medical Radiology Named after N.N.Aleksandrov", Minsk
"Federal State Educational Institution of Higher Education Baltic Federal University Named after Immanuel Kant", Kaliningrad
"Limited Liability Company Ars Medica Centre", Kaliningrad
"State Budgetary Healthcare Institution of Kaluga Region Kaluga Region Clinical Oncological Dispensary", Kaluga
"LLC New Clinic", Pyatigorsk
"State-financed Health Institution Samara Region Clinical Oncology Dispensary", Samara
Republican Clinical Oncology Dispensary of Ministry of Health republic Bashkortostan, Ufa
Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine, Chelyabinsk
"Nizhny Novgorod Region State Budgetary Healthcare Institution Nizhny Novgorod Regional Clinical Oncological Dispensary", Nizhny Novgorod
"State Budgetary Healthcare Institution of Novosibirsk Region Novosibirsk Region Clinical Oncological Dispensary", Novosibirsk
"Limited Liability Company Nebbiolo", Tomsk
"Regional State Budgetary Healthcare Institution Altai Regional Oncological Dispensary", Barnaul
"State Autonomous Health Institution Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal", Kazan'
"JSC Medsi Group", Moscow
Moscow City Oncology Hospital No. 62, Moscow
"State budgetary health care institution of the city of Moscow City Clinical Oncology Hospital No. 1 of the Department of Health of the City of Moscow", Moscow
"State Budgetary Healthcare Institution Moscow Clinical Scientific Center funded by Moscow Health Department (SBHI MCSC MHD)", Moscow
"State budget healthcare institution Omsk region Clinical Oncology Dispensary", Omsk
"Saint Petersburg Clinical Research and Practice Center for Specialized Medical Care (Oncology)", Saint Petersburg
"Federal State Budgetary Institution N.N. Petrov Research Institute of Oncology of the Ministry of Healthcare of the Russian Federation", Saint Petersburg
"Limited Liability Company Oncological Research Center", Saint Petersburg
Private Medical Institution Evromedservis, Saint Petersburg
"Federal State Educational Institution of Higher Professional Education Mordovia State University N.P. Ogareva ", Saransk
"State Health Care Institution Volgograd Regional Clinical Oncology Dispensary № 1", Volgograd
Lead Sponsor
Biocad
INDUSTRY